Page 60 - Inside_Low

This is a SEO version of Inside_Low. Click here to view full version

« Previous Page Table of Contents Next Page »
Belhoul Life care (BLC)
- Dubai, UAE’s private
healthcare frm has signed
an MOU with Bina Sehat
Hospital, Jembar – East
Java, Indonesia on 21st
March 2012 in Belhoul
Speciality Hospital at 3.30
“Belhoul Life care” is an
integration of all healthcare
facilities and services
offered by the Belhoul
Group Holdings, who
delivers the best medical
care to the regional
community. Belhoul
Lifecare has taken the
initiative to sign the MOU
with Bina Sehat Hospital to
recruit qualifed registered
nurses who has been
trained and oriented in
the training centre of Bina
Sehat Hospital.
Bina Sehat Hospital
established in 1995 as a
Medical Clinic emerged
as a Hospital in 2003 and
now is a hospital with a
capacity of 213 beds and
399 employees. 65% of the
total employees are nurses
and development of the
nursing staff has been
their primary concern.
Bina Seha training was
established to develop
the skills, body, mind
and soul of the nursing
human resources of Bina
Sehat Hospital through
specialized training and job
deployment programs.
BLC also aims in
developing the training
centre of Bina Sehat
Hospital into a nursing
school and will work as
partners in the nursing
school project. They will
establish two new nursing
schools, one in Surabaya
City and the other in Jakarta
City. BLC & Bina Sehat
Hospital has also agreed to
invest in general hospital in
Surabaya City. The hospital
will be a pilot investment for
other hospitals in Indonesia
in future.
BLC will support and
participate in the annual
charity treatment, which is
organized and supported by
the Bina Sehat Hospital in
Jember City.
A medical centre will be
established in Surabaya and
Jakarta, which will provide
medical check up services
for Indonesian employees
who will be traveling to UAE
as per the requirements of
UAE authorities.
The prostate gland is the male organ most
commonly afficted with either benign or
malignant neoplasms. It comprises the
most proximal aspect of the urethra. The
most common two diseases that affect the
prostate in men above 50 years old are Benign
Prostatic hyperplasia (BPH) and prostatic
malignancy . Lower urinary tract symptoms
( LUTS ), such as hesitancy, decreased
force and caliber of stream, sensation of
incomplete bladder emptying, double
voiding (urinating a second time within
2 hours of the previous void), straining
to urinate, post-void dribbling, urgency,
frequency, and nocturia , were found in
18%, 29%, 40%, and 56% of men in their
40s, 50s, 60s, and 70s having moderate to
severe symptoms .LUTS could be due to
several pathologies as BPH, Prostatitis ,
bladder neck obstruction (BNO ) , or over
active bladder ( OAB ) . It is important to
know that all LUTS affect the man sexual
life causing a mild to severe erectile
dysfunction and abnormal ejaculation
mainly pre mature ejaculation.
Benign prostatic hyperplasia (BPH) is a
pathologic process that contributes to, but
is not the sole cause of lower urinary tract
symptoms (LUTS) in aging men. BPH is the
most common benign tumor in men, and its
incidence is age related. The prevalence of
histologic BPH in autopsy studies rises from
approximately 20% in men aged 41–50,
to 50% in men aged 51–60, and to >90%
in men older than 80. Although clinical
evidence of disease occurs less commonly,
symptoms of prostatic obstruction are
also age related. At age 55, approximately
25% of men report obstructive voiding
symptoms. At age 75, 50% of men complain
of a decrease in the force and caliber of
their urinary stream. Risk factors for the
development of BPH are poorly understood.
Some studies have suggested a genetic
predisposition, and some have noted
racial differences. Approximately 50% of
men under the age of 60 who undergo
surgery for BPH may have a heritable form
of the disease. This form is most likely an
autosomal dominant trait, and frst-degree
male relatives of such patients carry an
increased relative risk of approximately
fourfold. Despite intense research efforts
in the past fve decades to elucidate the
underlying etiology of prostatic growth in
older men, cause-and-effect relationships
have not been established. The etiology of
BPH is not completely understood, but it
seems to be multifactorial and endocrine
Prostate cancer (CaP) has been the most
common visceral malignant neoplasm in
U.S. men since 1984, now accounting for
one third of all such cancers. The estimated
lifetime risk of disease is 17.6% for whites
and 20.6% for African Americans, with
a lifetime risk of death of 2.8% and 4.7%,
respectively. Although prostate cancer
is the second leading cause of cancer
death for men, mortality rates have been
declining since the mid-1990s. Of all
cancers, the prevalence of CaP increases
the most rapidly with age. However, unlike
most cancers, which have a peak age of
incidence, the incidence of CaP continues
to increase with advancing age. The
lifetime risk of a 50-year-old man for latent
CaP (detected as an incidental fnding
at autopsy, not related to the cause of
death) is 40%; for clinically apparent CaP,
9.5%; and for death from CaP, 2.9%. Thus,
many prostate cancers are indolent and
inconsequential to the patient while others
are virulent, and if detected too late or left
untreated, they result in a patient’s death.
This broad spectrum of biological activity
can make decision making for individual
patients diffcult.
For all what have been mentioned , it is
of at most importance for males above 40
years of age to have yearly assessment of
the prostate . The recommended routine
prostatic examination for men by the
European association of Urology includes
Physical examination with DRE, Urine
analysis , Prostatic specifc antigen (tumor
marker of prostate ), Urinary ultrasound ,
and Uro fowmetery .
In response , the Canadian Specialist
Hospital in Dubai launched the Prostate
Screening program for men above 40 years
of old. Our goal is not only treating men
with urologic diseases but also to prevent
possible urologic problem by detecting it in
its early stages to avoid or decrease serious
urologic problems .
Send your PR & News to